BRIEF

on Viromed Medical AG (isin : DE000A3MQR65)

Prof. Dr. Michael A. Rübhausen Joins Viromed Medical AG's Advisory Board

Viromed Medical AG has announced Prof. Dr. Michael A. Rübhausen's appointment to its Medical Advisory Board, effective immediately. This addition is expected to bolster the company's scientific evaluation capabilities at the nexus of material properties, spectroscopy, and cold plasma research.

Rübhausen leads the Optics Working Group at the Universität Hamburg and serves as the Managing Director. His prolific research covers modern spectroscopic methods applied in studying superconductors and quantum materials. His work is extensively published, with over 180 publications and roughly 4,000 citations in noted journals like Nature Communications.

The strategic move by Viromed, a medical technology firm and a pioneer in cold plasma applications, aims to harness his expertise to advance research and support their technological objectives, particularly in material properties and cold plasma intersection.

R. H.

Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all Viromed Medical AG news